This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A number of tech companies have made the headlines this week for hiring new members of staff, only to rescind such offers before they start. Get all the latest technews straight to your inbox. Mass Layoffs Taking Place. A False Start. The fintech firm has also laid off almost 20% of its workforce.
We use gestures or our voice to control our engagement with our technology. We are learning to use new tools. ChatGBT and Bing AI are just two of the new tools that are already changing our lives. It won’t be long before another round of layoffs comes, and these new tools will create new jobs to fill the gap.
Familiar biotech names—not necessarily familiar for the right reasons—made news this week in biotech. Despite technical differences and the early nature of the data that made comparison difficult, Wall Street declared Spark this week’s winner. You think a Game 7 in the NBA Finals is going to be epic? .
And then the news flowed, from a fast reprieve for Juno Therapeutics to no mercy for Elizabeth Holmes. All eyes are on Holmes, who is scheduled to present data from the company’s technology at a medical conference on August 1. —Enough good trial news. —In other Merck news, U.K.-based —With $1.25
military’s high-tech think tank DARPA described Safe Genes, a new program to fund safety measures that can be built into genome editing technology or counter its potential wayward effects. —The 2016 Nobel Prize for Physiology or Medicine went to Yoshinori Ohsumi of the Tokyo Institute of Technology.
There was plenty more biomedical news this week, from a downsized IPO to downsizing companies, while ugly sexual harassment details emerged in Seattle. If you want a roundup of the week’s biotech’s news, read on. The technology was funded by the Department of Defense and comes from MIT’s Lincoln Lab.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content